Structural insights into the covalent regulation of PAPP-A activity by proMBP and STC2

[1]  J. Jumper,et al.  Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition , 2022, Nature Communications.

[2]  N. Sang,et al.  Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target , 2022, Journal of experimental & clinical cancer research : CR.

[3]  C. Conover,et al.  Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy. , 2022, Metabolism: clinical and experimental.

[4]  M. DePristo,et al.  RNA profiles reveal signatures of future health and disease in pregnancy , 2022, Nature.

[5]  J. Qin,et al.  Establishment of Trophoblast‐Like Tissue Model from Human Pluripotent Stem Cells in Three‐Dimensional Culture System , 2021, Advanced science.

[6]  D. Hassabis,et al.  Protein complex prediction with AlphaFold-Multimer , 2021, bioRxiv.

[7]  K. Yanagihara,et al.  Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression , 2021, Molecular oncology.

[8]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[9]  A. Urban,et al.  PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta† , 2021, Biology of Reproduction.

[10]  R. Baron,et al.  Inhibition of longevity regulator PAPP‐A modulates tissue homeostasis via restraint of mesenchymal stromal cells , 2021, Aging cell.

[11]  Tiffany DeSouza,et al.  PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans , 2020, Science Translational Medicine.

[12]  G. Zuccotti,et al.  Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns , 2020, BMJ Open Diabetes Research & Care.

[13]  A. Urban,et al.  PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta† , 2020, Biology of Reproduction.

[14]  A. Joshi.  New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2 , 2020, Frontiers in Endocrinology.

[15]  J. Potempa,et al.  Structure-based mechanism of cysteine-switch latency and of catalysis by pappalysin-family metallopeptidases , 2020, IUCrJ.

[16]  S. Walker,et al.  The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development. , 2019, Placenta.

[17]  J. Frystyk,et al.  The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis , 2019, BMC Gastroenterology.

[18]  I. Sandovici,et al.  The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth , 2019, bioRxiv.

[19]  E. Hohenester.  Laminin G-like domains: dystroglycan-specific lectins. , 2019, Current opinion in structural biology.

[20]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[21]  R. Hjortebjerg.  IGFBP-4 and PAPP-A in normal physiology and disease. , 2018, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[22]  Cheng Zhu,et al.  Single-cell RNA-seq reveals the diversity of trophoblast subtypes and patterns of differentiation in the human placenta , 2018, Cell Research.

[23]  C. Conover,et al.  PAPP-A and cancer. , 2018, Journal of molecular endocrinology.

[24]  G. Kristiansen,et al.  Extravillous trophoblast invasion of venous as well as lymphatic vessels is altered in idiopathic, recurrent, spontaneous abortions , 2017, Human reproduction.

[25]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[26]  C. Conover,et al.  PAPP‐A: a promising therapeutic target for healthy longevity , 2016, Aging cell.

[27]  Marcelo P. Segura-Lepe,et al.  Rare and low-frequency coding variants alter human adult height , 2016, Nature.

[28]  C. Oxvig,et al.  PAPP-A and the IGF system. , 2016, Annales d'endocrinologie.

[29]  D. Tincello,et al.  Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. , 2015, Human reproduction update.

[30]  C. Oxvig,et al.  Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A* , 2015, The Journal of Biological Chemistry.

[31]  Kai Zhang,et al.  Gctf: Real-time CTF determination and correction , 2015, bioRxiv.

[32]  E. Füchtbauer,et al.  Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis* , 2014, The Journal of Biological Chemistry.

[33]  R. Baxter,et al.  IGF binding proteins in cancer: mechanistic and clinical insights , 2014, Nature Reviews Cancer.

[34]  J. Kopchick,et al.  The GH/IGF-1 axis in ageing and longevity , 2013, Nature Reviews Endocrinology.

[35]  M. Pollak.  The insulin and insulin-like growth factor receptor family in neoplasia: an update , 2012, Nature Reviews Cancer.

[36]  S. Glerup,et al.  Placental Regulation of Peptide Hormone and Growth Factor Activity by proMBP1 , 2011, Biology of reproduction.

[37]  N. Uldbjerg,et al.  Biology of pregnancy‐associated plasma protein‐A in relation to prenatal diagnostics: an overview , 2010, Acta obstetricia et gynecologica Scandinavica.

[38]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[39]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[40]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[41]  A. Chao,et al.  Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler , 2009, Prenatal Diagnosis.

[42]  M. V. van Gemert,et al.  Placental characteristics of monochorionic diamniotic twin pregnancies in relation to perinatal outcome. , 2008, Placenta.

[43]  M. Overgaard,et al.  Inhibition of the Proteolytic Activity of Pregnancy-associated Plasma Protein-A by Targeting Substrate Exosite Binding* , 2008, Journal of Biological Chemistry.

[44]  J. Deprest,et al.  A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[45]  M. Christiansen,et al.  Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence. , 2007, Clinical chemistry.

[46]  C. Oxvig,et al.  A Substrate Specificity-determining Unit of Three Lin12-Notch Repeat Modules Is Formed in Trans within the Pappalysin-1 Dimer and Requires a Sequence Stretch C-terminal to the Third Module* , 2007, Journal of Biological Chemistry.

[47]  M. E. Ferretti,et al.  Control of human trophoblast function , 2007, Reproductive biology and endocrinology : RB&E.

[48]  C. Conover,et al.  Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. , 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[49]  S. Thiel,et al.  Cell Surface Detachment of Pregnancy-associated Plasma Protein-A Requires the Formation of Intermolecular Proteinase-Inhibitor Disulfide Bonds and Glycosaminoglycan Covalently Bound to the Inhibitor* , 2007, Journal of Biological Chemistry.

[50]  U. Baumann,et al.  Substrate specificity of a metalloprotease of the pappalysin family revealed by an inhibitor and a product complex. , 2007, Archives of biochemistry and biophysics.

[51]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[52]  U. Baumann,et al.  Molecular Analysis of Ulilysin, the Structural Prototype of a New Family of Metzincin Metalloproteases* , 2006, Journal of Biological Chemistry.

[53]  David N Mastronarde,et al.  Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.

[54]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[55]  L. Giudice,et al.  The Lin12-Notch Repeats of Pregnancy-associated Plasma Protein-A Bind Calcium and Determine Its Proteolytic Specificity* , 2004, Journal of Biological Chemistry.

[56]  M. Overgaard,et al.  Proteolytic degradation of IGF-binding protein (IGFBP)-2 in equine ovarian follicles: involvement of pregnancy-associated plasma protein-A (PAPP-A) and association with dominant but not subordinated follicles. , 2004, The Journal of endocrinology.

[57]  L. Giudice,et al.  Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. , 2004, European journal of biochemistry.

[58]  B. Huppertz,et al.  Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia , 2003, Biology of reproduction.

[59]  J. E. Fortune,et al.  Selection of the dominant follicle and insulin-like growth factor (IGF)-binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF-binding protein 5 in bovine follicular fluid. , 2003, Endocrinology.

[60]  M. Overgaard,et al.  Complex of Pregnancy-associated Plasma Protein-A and the Proform of Eosinophil Major Basic Protein , 2003, The Journal of Biological Chemistry.

[61]  L. Giudice,et al.  Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic Activity , 2002, The Journal of Biological Chemistry.

[62]  Kathrin H Hopmann,et al.  Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. , 2002, The Biochemical journal.

[63]  K. Godfrey.  The role of the placenta in fetal programming-a review. , 2002, Placenta.

[64]  L. Giudice,et al.  Adhesion of pregnancy-associated plasma protein-A, PAGE 1 Cell surface targeting of pregnancy-associated plasma protein-A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats* , 2002 .

[65]  M. Overgaard,et al.  Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. , 2001, The Biochemical journal.

[66]  G. J. Swaminathan,et al.  Crystal Structure of the Eosinophil Major Basic Protein at 1.8 Å , 2001, Journal of Biological Chemistry.

[67]  C. Conover,et al.  Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor* , 2000, The Journal of Biological Chemistry.

[68]  S. Mohan,et al.  Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. , 2000, Archives of biochemistry and biophysics.

[69]  N. Wald,et al.  Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. , 1999, The New England journal of medicine.

[70]  N. Moody.  Untapped Potential , 1997 .

[71]  C. Oxvig,et al.  Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. , 1994, Biochimica et biophysica acta.

[72]  C. Oxvig,et al.  Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. , 1993, The Journal of biological chemistry.

[73]  K. Johnson.  An Update. , 1984, Journal of food protection.

[74]  J. Grudzinskas,et al.  Pregnancy-associated plasma protein A: circulating levels during normal pregnancy. , 1981, American journal of obstetrics and gynecology.

[75]  W. Spellacy,et al.  Characterization of four human pregnancy-associated plasma proteins. , 1974, American journal of obstetrics and gynecology.